Home
  >  
Section 6
  >  
Chapter 5,022

Compliance testing by measurement of piracetam in urine--a possible method of compliance control for piracetam intakers. An empirical investigation

Fischer, B.; Lehrl, S.; Schnaiter, A.; Schulz, H.U.; Salinger, W.; Fischer, U.; Weber, E.

Neuropsychobiology 10(1): 19-22

1983

ISSN/ISBN: 0302-282X
PMID: 6657035
DOI: 10.1159/000117979
Accession: 005021798
Download citation:  
Text
  |  
BibTeX
  |  
RIS
All teams of investigators concerned with compliance rate agree that patients do not reliably take their tablets as prescribed. In case of long-term medication the problem becomes even more acute. A method for checking on compliance is of great help in controlling medical therapy as well as in judging the effectiveness of pharmaceuticals. Apparently, diachronic determination of piracetam concentration in patients' urine is an especially simple way of testing compliance without undue strain on the patient.

Full Text Article emailed within 0-6 h: $19.90




Related References

Slavtschev, P.; Andonova, V.; Michailova, D.; Tomassini, L.; Yamboliev, I.; Drenska, A. 1985: Bioverfügbarkeit von zwei Piracetam-Präparaten - Biodisponibilité de 2 préparations de Piracetam - Bioavailability of two Piracetam preparations Pharmazie 40(6): 425-426
Von der Schulenburg Jm, G.; Greiner, W. 1998: Compliance und Asthma : eine Delphibefragung zur Therapietreue ambulant betreuter Asthmapatienten - Compliance and asthma : A Delphi method investigation on compliance in asthmatic patients das Gesundheitswesen (Stuttgart. Thieme) 60(10): 558-562
Sannita, W.G.; Balestra, V.; Rosadini, G.; Salama, M.; Timitilli, C. 1985: Quantitative EEG and neuropsychological effects of piracetam and of the association piracetam-lecithin in healthy volunteers Neuropsychobiology 14(4): 203-209
Malykh, A.G.; Sadaie, M.Reza. 2010: Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders Drugs 70(3): 287-312
Wheble, P.C.R.; Sena, E.S.; Macleod, M.R. 2008: A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke Cerebrovascular Diseases 25(1-2): 5-11
Gallinat, J.; Moller, H.J.; Hegerl, U. 1999: Piracetam in der Anästhesie zur Prophylaxe eines postoperativen Delirs - Use of piracetam in anaesthesia as prophylaxis against delirium Ains. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 34(9): 520-527
Spijer, G.; D.J.ng A.; Bakker, J. 1987: Piracetam and piracetam plus hemisphere specific stimulation effects on the reading performance of two subtyped dyslexic boys Journal of Clinical and Experimental Neuropsychology 9(3): 275-276
Aksu, F.; Gültekin, I.; Inan, S.Y.; Baysal, F. 1998: The effects of piracetam on morphine-induced amnesia and analgesia: the possible contribution of central opiatergic mechanisms on the antiamnestic effect of piracetam Inflammopharmacology 6(1): 53-65
Van Hout, A.; Giurgea, D. 1990: L'action du Piracetam sur la dyslexie - The effects of Piracetam in dyslexia Anae. Approche Neuropsychologique des Apprentissages chez l'Enfant 0002(0003): 00145-00152
Fischer, W.; Kittner, H.; Schubert, S. 1991: Zur Wirksamkeit von Piracetam, Meclofenoxat und Vinpocetin in verschiedenen Krampfmodellen bei der Maus - Effectiveness of piracetam, meclofenoxate and vinpocetine in different seizure tests on the mouse Pharmazie 46(5): 359-360
Koskiniemi, M.; Van Vleymen, B.; Hakamies, L.; Lamusuo, S.; Taalas, J. 1998: Piracetam relieves symptoms in progressive myoclonus epilepsy : a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo Journal of Neurology, Neurosurgery and Psychiatry 64(3): 344-348
Koskiniemi, M.; Van Vleymen, B.; Hakamies, L.; Lamusuo, S.; Taalas, J. 1998: Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo Journal of Neurology Neurosurgery and Psychiatry 64(3): 344-348
Herrschaft, H. 1988: The effectiveness of piracetam in acute cerebral ischemia in the human. a clinical controlled double-blind study of piracetam/10% dextran 40 versus 10% dextran 40/placebo Medizinische Klinik 83(20): 667-677
2000: Piracétam et myoclonies d'origine corticale: même à doses élevées, un intérêt très douteux - Piracetam and cortical myoclonus: Even at high doses, an incertain interest la Revue Prescrire 20(204): 180-182
Mathieu, J.; Ullmann, P. 1993: Traitement du vieillissement cérébral pathologique par le piracétam - Treatment of pathological cerebral ageing with piracetam Congres International de Psycho-Geriatrie 25(8): 817-822
Lim, W.S.; Gander, S.; Finch, R.G.; Macfarlane, J.T. 2000: A novel method for collecting and detecting amoxycillin in urine: a tool for testing antibiotic compliance in the community Journal of Antimicrobial ChemoTherapy 46(5): 835-837
Ferris, S.H.; Reisberg, B.; Crook, T.; Friedman, E.; Schneck, M.K.; Mir, P.; Sherman, K.A.; Corwin, J.; Gershon, S.; Bartus, R.T. 1982: Pharmacologic treatment of senile dementia choline l dopa piracetam and choline plus piracetam Corkin, S Et Al (Ed ) Aging, Vol 19 Alzheimer's Disease: A Report Of Progress in Research Xxvi+525p Raven Press: New York, N Y , Usa Illus P475-482
Eichfelder, S; Kegels, C 2014: Compliance costs caused by agency action? Empirical evidence and implications for tax compliance Journal of Economic Psychology 40: 200-219
Ikeda, A.; Shibasaki, H.; Tashiro, K.; Mizuno, Y.; Kimura, J. 1996: Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group Movement Disorders: Official Journal of the Movement Disorder Society 11(6): 691-700
Mühlig, S.; Bergmann, K.C.; Twesten, O.; Petermann, F. 2001: Therapy participation in ambulatory asthma patients: empirical comparison of compliance rates using different operationalization methods for drug compliance Pneumologie 55(4): 177-189